These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27410928)

  • 61. Olanzapine for chemotherapy-induced nausea and vomiting control.
    Radhakrishnan V; Seshadri RA; Nair S
    Lancet Oncol; 2024 May; 25(5):e174. PubMed ID: 38697157
    [No Abstract]   [Full Text] [Related]  

  • 62. Olanzapine for chemotherapy-induced nausea and vomiting control.
    Tsuruta S; Matsuguma K; Kawasaki N; Ishikawa A; Ishiki H
    Lancet Oncol; 2024 May; 25(5):e176. PubMed ID: 38697159
    [No Abstract]   [Full Text] [Related]  

  • 63. Olanzapine for chemotherapy-induced nausea and vomiting control.
    Sharma V; Dadheech A; Yadav A; Pehalajani JK; Somani N
    Lancet Oncol; 2024 May; 25(5):e175. PubMed ID: 38697158
    [No Abstract]   [Full Text] [Related]  

  • 64. Olanzapine 5 mg vs 10 mg for the prophylaxis of chemotherapy-induced nausea and vomiting: a network meta-analysis.
    Chow R; Navari RM; Terry B; DeAngelis C; Prsic EH
    Support Care Cancer; 2022 Feb; 30(2):1015-1018. PubMed ID: 34613472
    [No Abstract]   [Full Text] [Related]  

  • 65. Olanzapine for chemotherapy-induced nausea and vomiting control - Authors' reply.
    Bajpai J; Pawar A; Kapu V; Prabhash K
    Lancet Oncol; 2024 May; 25(5):e177. PubMed ID: 38697160
    [No Abstract]   [Full Text] [Related]  

  • 66. Patterns of nausea and vomiting in antineoplastic postchemotherapy patients.
    Rhodes VA; Watson PM; Johnson MH
    Appl Nurs Res; 1988 Nov; 1(3):143-4. PubMed ID: 3239997
    [No Abstract]   [Full Text] [Related]  

  • 67. Mechanisms and Management of Nausea and Emesis Associated with Cancer Therapy. Symposium proceedings. Marlow, United Kingdom, October 13-14, 1994.
    Oncology; 1996 Jun; 53 Suppl 1():1-110. PubMed ID: 8692543
    [No Abstract]   [Full Text] [Related]  

  • 68. Are 5-hydroxytryptamine-3 receptor antagonists efficient antiemetics for chemotherapy-induced delayed emesis and do they remain effective over subsequent cycles?
    Adenis A; Bonneterre J
    J Clin Oncol; 1994 Oct; 12(10):2235-6. PubMed ID: 7931495
    [No Abstract]   [Full Text] [Related]  

  • 69. Issues in antiemetic therapy.
    Goldspiel BR; Curt GA
    Cancer; 1996 Mar; 77(5):823-6. PubMed ID: 8608470
    [No Abstract]   [Full Text] [Related]  

  • 70. Antiemetic effect of nonabine in cancer chemotherapy: a double blind study comparing nonabine and chlorpromazine.
    Archer CB; Amlot PL; Trounce JR
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):350-1. PubMed ID: 6402096
    [No Abstract]   [Full Text] [Related]  

  • 71. Anticipatory nausea and vomiting.
    Aapro MS; Molassiotis A; Olver I
    Support Care Cancer; 2005 Feb; 13(2):117-21. PubMed ID: 15599779
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting.
    Swann IL; Thompson EN; Qureshi K
    Br Med J; 1979 Nov; 2(6199):1188. PubMed ID: 519355
    [No Abstract]   [Full Text] [Related]  

  • 73. New anti-emetic treatments.
    Roila F; Garassino M; Fatigoni S
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix43-7. PubMed ID: 17631595
    [No Abstract]   [Full Text] [Related]  

  • 74. Olanzapine: is it enough for CINV prevention?
    Tienchaiananda P; Nipondhkit W; Prasongsook N
    Ann Palliat Med; 2020 Jul; 9(4):2427-2429. PubMed ID: 32434367
    [No Abstract]   [Full Text] [Related]  

  • 75. [Cannabinoids and emesis: new evidences, new questions].
    Duran M; Abanades S; Farré M; Capellà D
    Med Clin (Barc); 2006 Jul; 127(6):237-8; author reply 238. PubMed ID: 16938247
    [No Abstract]   [Full Text] [Related]  

  • 76. Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.
    ; Herrstedt J
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii83-5. PubMed ID: 17491061
    [No Abstract]   [Full Text] [Related]  

  • 77. Promoting the use of oral ondansetron in children receiving cancer chemotherapy.
    Walker PC; Biglin KE; Constance TD; Bhambhani K; Sims-McCallum R
    Am J Health Syst Pharm; 2001 Apr; 58(7):598-602. PubMed ID: 11296610
    [No Abstract]   [Full Text] [Related]  

  • 78. Reply to: adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score.
    Burmeister H
    Support Care Cancer; 2013 Jan; 21(1):7. PubMed ID: 23142923
    [No Abstract]   [Full Text] [Related]  

  • 79. Caring for the cancer patient: managing emesis now. An interactive workshop. Proceedings of a satellite symposium to the 6th European Conference on Clinical Oncology. Florence, October 1991.
    Eur J Cancer; 1992; 28A Suppl 1():S1-44. PubMed ID: 1352697
    [No Abstract]   [Full Text] [Related]  

  • 80. New drugs, better treatments lessen side effects of cancer care.
    McCann J
    J Natl Cancer Inst; 2000 Mar; 92(6):449-51. PubMed ID: 10716960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.